UCLA Clinical Trial Targets Cancer Stem Cells: A Patient's Story

UCLA patient Frank Gonzalez talks about his experience participating in a clinical trial funded by California’s stem cell agency, CIRM. The trial is testing an experimental drug that targets cancer stem cells, which are thought to be responsible for cancer relapse.